Micheva-Viteva SN - Search Results

1

The Brucella TIR-like protein TcpB interacts with the death domain of MyD88.

Chaudhary A, Ganguly K, Cabantous S, Waldo GS, Micheva-Viteva SN, Nag K, Hlavacek WS, Tung CS. Chaudhary A, et al. Among authors: micheva viteva sn. Biochem Biophys Res Commun. 2012 Jan 6;417(1):299-304. doi: 10.1016/j.bbrc.2011.11.104. Epub 2011 Nov 29. Biochem Biophys Res Commun. 2012. PMID: 22155231 Free PMC article.

2

Functional and Structural Analysis of a Highly-Expressed Yersinia pestis Small RNA following Infection of Cultured Macrophages.

Li N, Hennelly SP, Stubben CJ, Micheva-Viteva S, Hu B, Shou Y, Vuyisich M, Tung CS, Chain PS, Sanbonmatsu KY, Hong-Geller E. Li N, et al. PLoS One. 2016 Dec 28;11(12):e0168915. doi: 10.1371/journal.pone.0168915. eCollection 2016. PLoS One. 2016. PMID: 28030576 Free PMC article.

3

PKC-η-MARCKS Signaling Promotes Intracellular Survival of Unopsonized Burkholderia thailandensis.

Micheva-Viteva SN, Shou Y, Ganguly K, Wu TH, Hong-Geller E. Micheva-Viteva SN, et al. Front Cell Infect Microbiol. 2017 Jun 7;7:231. doi: 10.3389/fcimb.2017.00231. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28638804 Free PMC article.

4

Selection and verification of antibodies against the cytoplasmic domain of M2 of influenza, a transmembrane protein.

Velappan N, Micheva-Viteva S, Adikari SH, Waldo GS, Lillo AM, Bradbury ARM. Velappan N, et al. MAbs. 2020 Jan-Dec;12(1):1843754. doi: 10.1080/19420862.2020.1843754. MAbs. 2020. PMID: 33206590 Free PMC article.

5

Nonclassical autophagy activation pathways are essential for production of infectious Influenza A virus in vitro.

Bell TAS, Velappan N, Gleasner CD, Xie G, Starkenburg SR, Waldo G, Banerjee S, Micheva-Viteva SN. Bell TAS, et al. Among authors: micheva viteva sn. Mol Microbiol. 2022 Feb;117(2):508-524. doi: 10.1111/mmi.14865. Epub 2022 Jan 6. Mol Microbiol. 2022. PMID: 34931347 Free PMC article.

6

Healthy humans can be a source of antibodies countering COVID-19.

Velappan N, Nguyen HB, Micheva-Viteva S, Bedinger D, Ye C, Mangadu B, Watts AJ, Meagher R, Bradfute S, Hu B, Waldo GS, Lillo AM. Velappan N, et al. Bioengineered. 2022 May;13(5):12598-12624. doi: 10.1080/21655979.2022.2076390. Bioengineered. 2022. PMID: 35599623 Free PMC article.

7

What Can Go Wrong When Applying Immune Modulation Therapies to Target Persistent Bacterial Infections.

Micheva-Viteva S, Hong-Geller E. Micheva-Viteva S, et al. J Cell Immunol. 2020;2(1):1-5. doi: 10.33696/immunology.2.011. Epub 2020 Jan 3. J Cell Immunol. 2020. PMID: 32395721 Free PMC article.

8

c-KIT signaling is targeted by pathogenic Yersinia to suppress the host immune response.

Micheva-Viteva SN, Shou Y, Nowak-Lovato KL, Rector KD, Hong-Geller E. Micheva-Viteva SN, et al. BMC Microbiol. 2013 Nov 9;13:249. doi: 10.1186/1471-2180-13-249. BMC Microbiol. 2013. PMID: 24206648 Free PMC article.

9

Functional gene discovery using RNA interference-based genomic screens to combat pathogen infection.

Hong-Geller E, Micheva-Viteva SN. Hong-Geller E, et al. Among authors: micheva viteva sn. Curr Drug Discov Technol. 2010 Jun;7(2):86-94. doi: 10.2174/157016310793180657. Curr Drug Discov Technol. 2010. PMID: 20836760 Review.

10

Counting small RNA in pathogenic bacteria.

Shepherd DP, Li N, Micheva-Viteva SN, Munsky B, Hong-Geller E, Werner JH. Shepherd DP, et al. Among authors: micheva viteva sn. Anal Chem. 2013 May 21;85(10):4938-43. doi: 10.1021/ac303792p. Epub 2013 Apr 25. Anal Chem. 2013. PMID: 23577771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page